UnknownNot Applicable

The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females

Denmark48 participantsStarted 2019-08-28

Plain-language summary

Recombinant human erythropoietin (rHuEPO) regimen enhances maximal oxygen consumption (VO2max), but the effect of micro-doses on maximal and submaximal performance is not clear and detection of micro-doses is difficult with current methods. This study investigated whether micro-doses of rHuEPO enhances maximal and endurance performance in males and females.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Relative maximum oxygen uptake (VO2-max) of at least 50 ml O2/min/kg for male participants and 45 ml O2/min/kg for female participants Exclusion Criteria: * Age * Insufficient fitness level * Blood donation 3 months prior to enrollment * Altitude exposure 2 months before enrollment * Hypertension

What they're measuring

Change in maximal oxygen uptake

Timeframe: Change from baseline to 5 days after last injection

Change in time trial performance

Timeframe: Change from baseline to 3 days after last injection

Change in total hemoglobin mass

Timeframe: Change from baseline to 3 days after last injection

Trial details

NCT IDNCT04965961

SponsorUniversity of Copenhagen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-17

View on ClinicalTrials.gov More Sports Drug Abuse trials